Sage Therapeutics
ZULRESSO
Manufacturer:
Sage Therapeutics
Name:
ZULRESSO
HCPCS Code Descriptor:
Injection, brexanolone, 1 mg
Category:
J Code
HCPCS:
J1632
NDC(s):
72152-0547-20
Primary Type:
Anti-Depressant
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ZULRESSO is an Anti-Depressant drug manufactured by Sage Therapeutics and administered via the Intravenous route of administration. The J Code: J1632 is aligned to the drug ZULRESSO.